nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.0351	0.0388	CcSEcCtD
Terazosin—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0223	0.0246	CcSEcCtD
Terazosin—Neck pain—Telbivudine—hepatitis B	0.0174	0.0192	CcSEcCtD
Terazosin—Musculoskeletal pain—Telbivudine—hepatitis B	0.0174	0.0192	CcSEcCtD
Terazosin—KCNH6—Voltage gated Potassium channels—KCNH1—hepatitis B	0.017	0.178	CbGpPWpGaD
Terazosin—Anaphylactoid reaction—Entecavir—hepatitis B	0.0157	0.0173	CcSEcCtD
Terazosin—KCNH7—Voltage gated Potassium channels—KCNH1—hepatitis B	0.0152	0.158	CbGpPWpGaD
Terazosin—Amblyopia—Lamivudine—hepatitis B	0.0125	0.0139	CcSEcCtD
Terazosin—Pain in extremity—Telbivudine—hepatitis B	0.0125	0.0138	CcSEcCtD
Terazosin—Migraine—Telbivudine—hepatitis B	0.0123	0.0136	CcSEcCtD
Terazosin—Nasopharyngitis—Telbivudine—hepatitis B	0.0111	0.0123	CcSEcCtD
Terazosin—Jaundice—Adefovir Dipivoxil—hepatitis B	0.0111	0.0123	CcSEcCtD
Terazosin—Gastritis—Telbivudine—hepatitis B	0.011	0.0122	CcSEcCtD
Terazosin—Vasodilation procedure—Lamivudine—hepatitis B	0.011	0.0122	CcSEcCtD
Terazosin—Vasodilation—Lamivudine—hepatitis B	0.011	0.0122	CcSEcCtD
Terazosin—Influenza—Telbivudine—hepatitis B	0.0108	0.0119	CcSEcCtD
Terazosin—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.0107	0.0118	CcSEcCtD
Terazosin—Oedema peripheral—Entecavir—hepatitis B	0.0103	0.0114	CcSEcCtD
Terazosin—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.0102	0.0112	CcSEcCtD
Terazosin—Musculoskeletal pain—Lamivudine—hepatitis B	0.00979	0.0108	CcSEcCtD
Terazosin—Malnutrition—Entecavir—hepatitis B	0.00913	0.0101	CcSEcCtD
Terazosin—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00891	0.00985	CcSEcCtD
Terazosin—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00878	0.00971	CcSEcCtD
Terazosin—KCNH6—Potassium Channels—KCNH1—hepatitis B	0.00873	0.0911	CbGpPWpGaD
Terazosin—Back pain—Adefovir Dipivoxil—hepatitis B	0.00862	0.00953	CcSEcCtD
Terazosin—Pharyngitis—Telbivudine—hepatitis B	0.00855	0.00946	CcSEcCtD
Terazosin—KCNH7—Potassium Channels—KCNH1—hepatitis B	0.00778	0.0812	CbGpPWpGaD
Terazosin—Cough—Adefovir Dipivoxil—hepatitis B	0.00777	0.0086	CcSEcCtD
Terazosin—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00758	0.00839	CcSEcCtD
Terazosin—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00758	0.00839	CcSEcCtD
Terazosin—Malnutrition—Telbivudine—hepatitis B	0.0075	0.0083	CcSEcCtD
Terazosin—Anaphylactic shock—Entecavir—hepatitis B	0.00745	0.00824	CcSEcCtD
Terazosin—Dysgeusia—Telbivudine—hepatitis B	0.00735	0.00812	CcSEcCtD
Terazosin—Back pain—Telbivudine—hepatitis B	0.00726	0.00802	CcSEcCtD
Terazosin—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00712	0.00787	CcSEcCtD
Terazosin—Ill-defined disorder—Telbivudine—hepatitis B	0.00696	0.0077	CcSEcCtD
Terazosin—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00693	0.00767	CcSEcCtD
Terazosin—Migraine—Lamivudine—hepatitis B	0.00691	0.00764	CcSEcCtD
Terazosin—Malaise—Telbivudine—hepatitis B	0.00676	0.00748	CcSEcCtD
Terazosin—Insomnia—Entecavir—hepatitis B	0.00674	0.00745	CcSEcCtD
Terazosin—Somnolence—Entecavir—hepatitis B	0.00662	0.00733	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00662	0.00733	CcSEcCtD
Terazosin—Dyspepsia—Entecavir—hepatitis B	0.00656	0.00725	CcSEcCtD
Terazosin—Cough—Telbivudine—hepatitis B	0.00655	0.00724	CcSEcCtD
Terazosin—Fatigue—Entecavir—hepatitis B	0.00642	0.00711	CcSEcCtD
Terazosin—KCNH2—Voltage gated Potassium channels—KCNH1—hepatitis B	0.00642	0.067	CbGpPWpGaD
Terazosin—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.0064	0.00708	CcSEcCtD
Terazosin—Arthralgia—Telbivudine—hepatitis B	0.00639	0.00706	CcSEcCtD
Terazosin—Chest pain—Telbivudine—hepatitis B	0.00639	0.00706	CcSEcCtD
Terazosin—Myalgia—Telbivudine—hepatitis B	0.00639	0.00706	CcSEcCtD
Terazosin—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00632	0.00699	CcSEcCtD
Terazosin—Discomfort—Telbivudine—hepatitis B	0.00631	0.00698	CcSEcCtD
Terazosin—Nasopharyngitis—Lamivudine—hepatitis B	0.00628	0.00694	CcSEcCtD
Terazosin—Gastrointestinal pain—Entecavir—hepatitis B	0.00609	0.00674	CcSEcCtD
Terazosin—Influenza—Lamivudine—hepatitis B	0.00607	0.00671	CcSEcCtD
Terazosin—Thrombocytopenia—Telbivudine—hepatitis B	0.00599	0.00663	CcSEcCtD
Terazosin—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00595	0.00658	CcSEcCtD
Terazosin—Abdominal pain—Entecavir—hepatitis B	0.00589	0.00652	CcSEcCtD
Terazosin—Body temperature increased—Entecavir—hepatitis B	0.00589	0.00652	CcSEcCtD
Terazosin—Bronchitis—Lamivudine—hepatitis B	0.00583	0.00645	CcSEcCtD
Terazosin—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00575	0.00636	CcSEcCtD
Terazosin—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00575	0.00636	CcSEcCtD
Terazosin—Dysuria—Lamivudine—hepatitis B	0.00567	0.00627	CcSEcCtD
Terazosin—Pollakiuria—Lamivudine—hepatitis B	0.0056	0.0062	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00558	0.00617	CcSEcCtD
Terazosin—Insomnia—Telbivudine—hepatitis B	0.00554	0.00612	CcSEcCtD
Terazosin—Paraesthesia—Telbivudine—hepatitis B	0.0055	0.00608	CcSEcCtD
Terazosin—Depression—Lamivudine—hepatitis B	0.00539	0.00597	CcSEcCtD
Terazosin—Dyspepsia—Telbivudine—hepatitis B	0.00539	0.00596	CcSEcCtD
Terazosin—Asthenia—Entecavir—hepatitis B	0.00535	0.00591	CcSEcCtD
Terazosin—Fatigue—Telbivudine—hepatitis B	0.00528	0.00584	CcSEcCtD
Terazosin—Jaundice—Lamivudine—hepatitis B	0.00527	0.00583	CcSEcCtD
Terazosin—Pain—Telbivudine—hepatitis B	0.00523	0.00579	CcSEcCtD
Terazosin—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00522	0.00577	CcSEcCtD
Terazosin—Sweating—Lamivudine—hepatitis B	0.00519	0.00574	CcSEcCtD
Terazosin—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00514	0.00569	CcSEcCtD
Terazosin—Epistaxis—Lamivudine—hepatitis B	0.0051	0.00564	CcSEcCtD
Terazosin—Diarrhoea—Entecavir—hepatitis B	0.0051	0.00564	CcSEcCtD
Terazosin—Sinusitis—Lamivudine—hepatitis B	0.00507	0.00561	CcSEcCtD
Terazosin—Feeling abnormal—Telbivudine—hepatitis B	0.00504	0.00558	CcSEcCtD
Terazosin—Gastrointestinal pain—Telbivudine—hepatitis B	0.00501	0.00554	CcSEcCtD
Terazosin—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00497	0.0055	CcSEcCtD
Terazosin—Dizziness—Entecavir—hepatitis B	0.00493	0.00545	CcSEcCtD
Terazosin—Rhinitis—Lamivudine—hepatitis B	0.00487	0.00538	CcSEcCtD
Terazosin—Abdominal pain—Telbivudine—hepatitis B	0.00484	0.00535	CcSEcCtD
Terazosin—Body temperature increased—Telbivudine—hepatitis B	0.00484	0.00535	CcSEcCtD
Terazosin—Pharyngitis—Lamivudine—hepatitis B	0.00482	0.00533	CcSEcCtD
Terazosin—Vomiting—Entecavir—hepatitis B	0.00474	0.00524	CcSEcCtD
Terazosin—Rash—Entecavir—hepatitis B	0.0047	0.0052	CcSEcCtD
Terazosin—Dermatitis—Entecavir—hepatitis B	0.00469	0.00519	CcSEcCtD
Terazosin—Headache—Entecavir—hepatitis B	0.00467	0.00516	CcSEcCtD
Terazosin—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00462	0.00511	CcSEcCtD
Terazosin—Rash—Adefovir Dipivoxil—hepatitis B	0.00458	0.00507	CcSEcCtD
Terazosin—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00458	0.00507	CcSEcCtD
Terazosin—Headache—Adefovir Dipivoxil—hepatitis B	0.00455	0.00504	CcSEcCtD
Terazosin—Nausea—Entecavir—hepatitis B	0.00443	0.0049	CcSEcCtD
Terazosin—Asthenia—Telbivudine—hepatitis B	0.00439	0.00486	CcSEcCtD
Terazosin—Pruritus—Telbivudine—hepatitis B	0.00433	0.00479	CcSEcCtD
Terazosin—Nausea—Adefovir Dipivoxil—hepatitis B	0.00432	0.00478	CcSEcCtD
Terazosin—Malnutrition—Lamivudine—hepatitis B	0.00423	0.00468	CcSEcCtD
Terazosin—Diarrhoea—Telbivudine—hepatitis B	0.00419	0.00463	CcSEcCtD
Terazosin—Flatulence—Lamivudine—hepatitis B	0.00417	0.00461	CcSEcCtD
Terazosin—Tension—Lamivudine—hepatitis B	0.00415	0.00459	CcSEcCtD
Terazosin—Dysgeusia—Lamivudine—hepatitis B	0.00414	0.00458	CcSEcCtD
Terazosin—Nervousness—Lamivudine—hepatitis B	0.00411	0.00454	CcSEcCtD
Terazosin—Back pain—Lamivudine—hepatitis B	0.00409	0.00452	CcSEcCtD
Terazosin—Dizziness—Telbivudine—hepatitis B	0.00405	0.00448	CcSEcCtD
Terazosin—Tremor—Lamivudine—hepatitis B	0.00396	0.00438	CcSEcCtD
Terazosin—Ill-defined disorder—Lamivudine—hepatitis B	0.00392	0.00434	CcSEcCtD
Terazosin—Vomiting—Telbivudine—hepatitis B	0.00389	0.0043	CcSEcCtD
Terazosin—Angioedema—Lamivudine—hepatitis B	0.00386	0.00427	CcSEcCtD
Terazosin—Rash—Telbivudine—hepatitis B	0.00386	0.00427	CcSEcCtD
Terazosin—Dermatitis—Telbivudine—hepatitis B	0.00386	0.00426	CcSEcCtD
Terazosin—Headache—Telbivudine—hepatitis B	0.00384	0.00424	CcSEcCtD
Terazosin—Malaise—Lamivudine—hepatitis B	0.00381	0.00422	CcSEcCtD
Terazosin—KCNH6—Neuronal System—KCNH1—hepatitis B	0.00381	0.0398	CbGpPWpGaD
Terazosin—Vertigo—Lamivudine—hepatitis B	0.0038	0.0042	CcSEcCtD
Terazosin—Syncope—Lamivudine—hepatitis B	0.00379	0.00419	CcSEcCtD
Terazosin—Loss of consciousness—Lamivudine—hepatitis B	0.00372	0.00411	CcSEcCtD
Terazosin—Cough—Lamivudine—hepatitis B	0.00369	0.00408	CcSEcCtD
Terazosin—Convulsion—Lamivudine—hepatitis B	0.00366	0.00405	CcSEcCtD
Terazosin—Nausea—Telbivudine—hepatitis B	0.00364	0.00402	CcSEcCtD
Terazosin—Myalgia—Lamivudine—hepatitis B	0.0036	0.00398	CcSEcCtD
Terazosin—Chest pain—Lamivudine—hepatitis B	0.0036	0.00398	CcSEcCtD
Terazosin—Arthralgia—Lamivudine—hepatitis B	0.0036	0.00398	CcSEcCtD
Terazosin—Anxiety—Lamivudine—hepatitis B	0.00359	0.00397	CcSEcCtD
Terazosin—Discomfort—Lamivudine—hepatitis B	0.00356	0.00393	CcSEcCtD
Terazosin—Dry mouth—Lamivudine—hepatitis B	0.00352	0.00389	CcSEcCtD
Terazosin—Confusional state—Lamivudine—hepatitis B	0.00348	0.00385	CcSEcCtD
Terazosin—Oedema—Lamivudine—hepatitis B	0.00345	0.00382	CcSEcCtD
Terazosin—Anaphylactic shock—Lamivudine—hepatitis B	0.00345	0.00382	CcSEcCtD
Terazosin—KCNH7—Neuronal System—KCNH1—hepatitis B	0.0034	0.0355	CbGpPWpGaD
Terazosin—Shock—Lamivudine—hepatitis B	0.00339	0.00375	CcSEcCtD
Terazosin—Thrombocytopenia—Lamivudine—hepatitis B	0.00338	0.00374	CcSEcCtD
Terazosin—Hyperhidrosis—Lamivudine—hepatitis B	0.00334	0.00369	CcSEcCtD
Terazosin—KCNH2—Potassium Channels—KCNH1—hepatitis B	0.0033	0.0344	CbGpPWpGaD
Terazosin—Anorexia—Lamivudine—hepatitis B	0.00329	0.00364	CcSEcCtD
Terazosin—Hypotension—Lamivudine—hepatitis B	0.00322	0.00357	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00314	0.00348	CcSEcCtD
Terazosin—Insomnia—Lamivudine—hepatitis B	0.00312	0.00345	CcSEcCtD
Terazosin—Paraesthesia—Lamivudine—hepatitis B	0.0031	0.00343	CcSEcCtD
Terazosin—Dyspnoea—Lamivudine—hepatitis B	0.00308	0.0034	CcSEcCtD
Terazosin—Somnolence—Lamivudine—hepatitis B	0.00307	0.00339	CcSEcCtD
Terazosin—Dyspepsia—Lamivudine—hepatitis B	0.00304	0.00336	CcSEcCtD
Terazosin—Decreased appetite—Lamivudine—hepatitis B	0.003	0.00332	CcSEcCtD
Terazosin—Fatigue—Lamivudine—hepatitis B	0.00297	0.00329	CcSEcCtD
Terazosin—Constipation—Lamivudine—hepatitis B	0.00295	0.00326	CcSEcCtD
Terazosin—Pain—Lamivudine—hepatitis B	0.00295	0.00326	CcSEcCtD
Terazosin—Feeling abnormal—Lamivudine—hepatitis B	0.00284	0.00314	CcSEcCtD
Terazosin—Gastrointestinal pain—Lamivudine—hepatitis B	0.00282	0.00312	CcSEcCtD
Terazosin—Abdominal pain—Lamivudine—hepatitis B	0.00273	0.00302	CcSEcCtD
Terazosin—Body temperature increased—Lamivudine—hepatitis B	0.00273	0.00302	CcSEcCtD
Terazosin—Hypersensitivity—Lamivudine—hepatitis B	0.00254	0.00281	CcSEcCtD
Terazosin—Asthenia—Lamivudine—hepatitis B	0.00248	0.00274	CcSEcCtD
Terazosin—Pruritus—Lamivudine—hepatitis B	0.00244	0.0027	CcSEcCtD
Terazosin—Diarrhoea—Lamivudine—hepatitis B	0.00236	0.00261	CcSEcCtD
Terazosin—Dizziness—Lamivudine—hepatitis B	0.00228	0.00252	CcSEcCtD
Terazosin—Vomiting—Lamivudine—hepatitis B	0.00219	0.00243	CcSEcCtD
Terazosin—Rash—Lamivudine—hepatitis B	0.00218	0.00241	CcSEcCtD
Terazosin—Dermatitis—Lamivudine—hepatitis B	0.00217	0.0024	CcSEcCtD
Terazosin—Headache—Lamivudine—hepatitis B	0.00216	0.00239	CcSEcCtD
Terazosin—Nausea—Lamivudine—hepatitis B	0.00205	0.00227	CcSEcCtD
Terazosin—KCNH2—Neuronal System—KCNH1—hepatitis B	0.00144	0.015	CbGpPWpGaD
Terazosin—ADRA1B—AMPK Signaling—HNF4A—hepatitis B	0.00123	0.0128	CbGpPWpGaD
Terazosin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00122	0.0127	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.00113	0.0118	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—FAS—hepatitis B	0.00112	0.0117	CbGpPWpGaD
Terazosin—ADRA1A—AMPK Signaling—HNF4A—hepatitis B	0.00109	0.0114	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—NOS2—hepatitis B	0.000961	0.01	CbGpPWpGaD
Terazosin—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000728	0.00759	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Other—CCR5—hepatitis B	0.000651	0.00679	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—IL10—hepatitis B	0.00065	0.00678	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—PTEN—hepatitis B	0.000616	0.00643	CbGpPWpGaD
Terazosin—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—hepatitis B	0.000593	0.00619	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000518	0.0054	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—TP53—hepatitis B	0.00042	0.00439	CbGpPWpGaD
Terazosin—ADRA1B—LPA receptor mediated events—NFKB1—hepatitis B	0.000387	0.00404	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—IL6—hepatitis B	0.000385	0.00402	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000382	0.00398	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000382	0.00398	CbGpPWpGaD
Terazosin—ADRA1B—AMPK Signaling—CDKN1A—hepatitis B	0.000367	0.00383	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.000355	0.0037	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000342	0.00357	CbGpPWpGaD
Terazosin—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000338	0.00353	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.000336	0.00351	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000328	0.00342	CbGpPWpGaD
Terazosin—ADRA1A—AMPK Signaling—CDKN1A—hepatitis B	0.000326	0.0034	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000318	0.00332	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—F2—hepatitis B	0.000314	0.00328	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000312	0.00326	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000311	0.00325	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000307	0.00321	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000283	0.00295	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000281	0.00293	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—F2—hepatitis B	0.000261	0.00272	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000259	0.00271	CbGpPWpGaD
Terazosin—ADRA1B—AMPK Signaling—TP53—hepatitis B	0.00025	0.00261	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000247	0.00258	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000242	0.00253	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CXCL10—hepatitis B	0.000238	0.00248	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000235	0.00245	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000233	0.00243	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—F2—hepatitis B	0.000231	0.00241	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.00023	0.0024	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IFNG—hepatitis B	0.000225	0.00234	CbGpPWpGaD
Terazosin—ADRA1A—AMPK Signaling—TP53—hepatitis B	0.000222	0.00232	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000209	0.00218	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000208	0.00217	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000207	0.00216	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000201	0.0021	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—IL6—hepatitis B	0.0002	0.00208	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IL2—hepatitis B	0.000199	0.00208	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CXCL10—hepatitis B	0.000197	0.00206	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—CCR5—hepatitis B	0.000185	0.00193	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RIT2—hepatitis B	0.000183	0.00191	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SAG—hepatitis B	0.000183	0.00191	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000179	0.00186	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CXCL10—hepatitis B	0.000175	0.00183	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000175	0.00183	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000173	0.0018	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000169	0.00176	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—F2—hepatitis B	0.000158	0.00165	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—TGFB1—hepatitis B	0.000156	0.00162	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000153	0.0016	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CCR5—hepatitis B	0.000153	0.0016	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SAG—hepatitis B	0.000152	0.00158	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RIT2—hepatitis B	0.000152	0.00158	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—TNF—hepatitis B	0.000145	0.00152	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CCR5—hepatitis B	0.000136	0.00142	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SAG—hepatitis B	0.000135	0.00141	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RIT2—hepatitis B	0.000135	0.00141	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CXCL10—hepatitis B	0.000134	0.0014	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—F2—hepatitis B	0.000131	0.00137	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCL10—hepatitis B	0.000122	0.00127	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—F2—hepatitis B	0.000117	0.00122	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCL10—hepatitis B	0.000112	0.00116	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.000111	0.00116	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CCR5—hepatitis B	0.000104	0.00109	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCL10—hepatitis B	0.000101	0.00106	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCL10—hepatitis B	9.91e-05	0.00103	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	9.5e-05	0.000992	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCR5—hepatitis B	9.47e-05	0.000988	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKR1B1—hepatitis B	9.36e-05	0.000977	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	9.28e-05	0.000969	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	9.26e-05	0.000967	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	9.22e-05	0.000962	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	9.22e-05	0.000962	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCL10—hepatitis B	9e-05	0.000939	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GGT2—hepatitis B	8.97e-05	0.000936	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—F2—hepatitis B	8.95e-05	0.000934	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CCR5—hepatitis B	8.65e-05	0.000903	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	8.19e-05	0.000855	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—F2—hepatitis B	8.12e-05	0.000848	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCR5—hepatitis B	7.86e-05	0.00082	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CCR5—hepatitis B	7.69e-05	0.000802	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	7.68e-05	0.000801	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—F2—hepatitis B	7.43e-05	0.000775	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCL10—hepatitis B	7.21e-05	0.000753	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	7.17e-05	0.000748	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCR5—hepatitis B	6.98e-05	0.000728	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—F2—hepatitis B	6.74e-05	0.000704	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—F2—hepatitis B	6.6e-05	0.000688	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	6.32e-05	0.00066	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—IL2—hepatitis B	6.02e-05	0.000629	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—F2—hepatitis B	5.99e-05	0.000625	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL10—hepatitis B	5.99e-05	0.000625	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCR5—hepatitis B	5.59e-05	0.000584	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL2—hepatitis B	5.47e-05	0.000571	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP2A6—hepatitis B	5.44e-05	0.000567	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL10—hepatitis B	5.32e-05	0.000555	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—IL2—hepatitis B	5e-05	0.000522	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GOT2—hepatitis B	4.92e-05	0.000513	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	4.82e-05	0.000503	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—F2—hepatitis B	4.8e-05	0.000501	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCR5—hepatitis B	4.64e-05	0.000484	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL2—hepatitis B	4.54e-05	0.000474	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—IL2—hepatitis B	4.44e-05	0.000463	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GGT1—hepatitis B	4.24e-05	0.000443	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GOT1—hepatitis B	4.24e-05	0.000443	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCR5—hepatitis B	4.12e-05	0.00043	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL2—hepatitis B	4.03e-05	0.000421	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—F2—hepatitis B	3.98e-05	0.000416	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—F2—hepatitis B	3.54e-05	0.000369	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL2—hepatitis B	3.23e-05	0.000337	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6—hepatitis B	3.22e-05	0.000336	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CTNNB1—hepatitis B	3.12e-05	0.000326	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CDKN1A—hepatitis B	3.05e-05	0.000318	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTEN—hepatitis B	3.04e-05	0.000317	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NFKB1—hepatitis B	3.03e-05	0.000316	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL2—hepatitis B	2.68e-05	0.00028	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6—hepatitis B	2.67e-05	0.000279	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CTNNB1—hepatitis B	2.59e-05	0.00027	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CDKN1A—hepatitis B	2.53e-05	0.000264	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTEN—hepatitis B	2.52e-05	0.000263	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TGFB1—hepatitis B	2.52e-05	0.000263	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NFKB1—hepatitis B	2.51e-05	0.000262	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL2—hepatitis B	2.38e-05	0.000249	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6—hepatitis B	2.37e-05	0.000247	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CTNNB1—hepatitis B	2.3e-05	0.00024	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALB—hepatitis B	2.26e-05	0.000236	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CDKN1A—hepatitis B	2.25e-05	0.000234	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTEN—hepatitis B	2.24e-05	0.000234	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NFKB1—hepatitis B	2.23e-05	0.000233	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TGFB1—hepatitis B	2.09e-05	0.000218	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TP53—hepatitis B	2.08e-05	0.000217	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6—hepatitis B	1.9e-05	0.000198	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TGFB1—hepatitis B	1.86e-05	0.000194	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTEN—hepatitis B	1.72e-05	0.00018	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TP53—hepatitis B	1.72e-05	0.00018	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6—hepatitis B	1.58e-05	0.000165	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TP53—hepatitis B	1.53e-05	0.00016	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6—hepatitis B	1.4e-05	0.000146	CbGpPWpGaD
